about
Leptin inhibits proliferation of breast cancer cells at supraphysiological concentrations by inhibiting mitogen-activated protein kinase signalingSystematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities.Effectiveness of long-term (twelve months) nonsurgical weight loss interventions for obese women with polycystic ovary syndrome: a systematic reviewLong-term weight loss effects on all cause mortality in overweight/obese populations.Effect of weight loss on adipokine levels in obese patients.Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes--a systematic review.What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials.Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review.Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.The effect of very low-calorie diets on renal and hepatic outcomes: a systematic review.Very-low-energy diets and morbidity: a systematic review of longer-term evidence.A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer.Evidence that a polymorphism within the 3'UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancerWeight loss for individuals with type 2 diabetes following a very-low-calorie diet in a community-based setting with trained facilitators for 12 weeks.Lactic acidosis due to metformin therapy in a low risk patient.Over-the-counter orlistat: early experiences, views and attitudes of community pharmacists in Great Britain.Glucose uptake by the brain on chronic high-protein weight-loss diets with either moderate or low amounts of carbohydrate.Long-term weight loss maintenance and management following a VLCD: a 3-year outcome.The Counterweight programme: Prevalence of CVD risk factors by body mass index and the impact of 10% weight change.Long-term cost-effectiveness of weight management in primary care.Plasma-specific proteins: their response to surgical trauma and tumour load, and modification of this response by post-operative metabolic support.The protein metabolic response to short-term starvation in man.Minimal access surgery for cholelithiasis induces an attenuated acute phase response.The role of degradation in the acute control of protein balance in adult man: failure of feeding to stimulate protein synthesis as assessed by L-[1-13C]leucin infusion.Empowering primary care to tackle the obesity epidemic: the Counterweight ProgrammeThe molecular contribution of TNF-α in the link between obesity and breast cancerOptimizing acceptability and feasibility of an evidence-based behavioral intervention for obese adults with obesity-related co-morbidities or additional risk factors for co-morbidities: An open-pilot intervention study in secondary careGlomerulotubular function in patients undergoing moderate surgical stressLithium clearance measurements during recombinant interleukin 2 treatment: tubular dysfunction in manModulation of the cytokine and acute-phase response to major surgery by recombinant interleukin-2Anaemia in diabetic renal disease: an underestimated risk factorEfficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group
P50
Q33778370-716B1A43-122A-469E-B8AF-52F5025F9D1DQ34013331-1DECF76F-46D1-46CF-81E1-7EA1701F8828Q34345731-68DC506D-36BC-4AA1-926A-FF8D885620A4Q34703871-48574124-A667-4DBA-B468-66E477967330Q35178805-6F4E2A7E-4098-4E9A-8672-5A079A58F353Q35640344-920FE0F3-7939-4A20-86DD-3DB19652CEAAQ35834681-3F0D6453-2695-4F05-9930-A567486892D0Q36129463-1EDBF23A-817F-4D6D-A643-9B16B9CDA2C3Q36176816-FB3551B0-251C-4B30-82A9-AF8CBF1F9D23Q37233319-88E669D5-4793-4466-9F77-2D4DFCA32FECQ38026643-059BCBAF-0892-45B4-9CF2-D673C03EE3DCQ39344660-63DBC4F4-DDE6-49C6-BDED-32AC2C5FEE8DQ40622441-251617EB-6E55-481D-9753-15639DF59ED9Q41585745-550DFC98-7D23-48D0-9B1C-1BD5F984CD4FQ43252828-DEC93770-1215-4B03-A87B-0C922159BF0EQ46084354-81DC69E3-698D-49B3-91DA-2D153DA45AF5Q47183294-49B0E7DE-9089-405F-BE31-419269AE8A2CQ47191864-78D3BC60-3272-4686-B68A-50923B6772BAQ47244668-A329E874-38E2-4801-9DAC-79B7DAB1CC7CQ47438542-013937A2-C4C2-4711-B303-4E95D327C5F6Q47904300-D692747E-DD28-43A7-83FF-8875B95D63B8Q47904860-E9900C2F-D7CF-41D2-97AC-86D6B45B65C8Q50153450-1BA50A6C-B5E9-4B54-89DC-B5E0FDA0E2E9Q51622111-54B69588-026B-4BA9-BCCA-73DA1D3FEEFAQ60209761-0AE4DB09-042D-40C1-A919-CE57E85EA0D0Q60287343-5B249AA3-9CFA-49B2-A3C6-F67593BC7B6EQ61183322-C9F5A160-E6EE-4E95-9D02-82591C9C9D3AQ68218286-41268641-0496-4A34-9194-5027EE43770AQ70652040-2C989B56-95B5-4276-A143-BAF07E08F9D8Q72609987-73C6FE47-11A3-4EFF-B2CB-E2123017F527Q74207444-A03082B7-1C77-4317-9ECF-AF234A18209FQ74648679-74CC4EEF-313C-401F-998F-0791D1F7BF0A
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Iain Broom
@ast
Iain Broom
@en
Iain Broom
@es
Iain Broom
@nl
Iain Broom
@sl
type
label
Iain Broom
@ast
Iain Broom
@en
Iain Broom
@es
Iain Broom
@nl
Iain Broom
@sl
altLabel
Iain Broom
@en
prefLabel
Iain Broom
@ast
Iain Broom
@en
Iain Broom
@es
Iain Broom
@nl
Iain Broom
@sl
P106
P1153
7004287710
P2038
John_Iain_Broom
P21
P31
P496
0000-0001-8941-2236